Leuphasyl dosing & administration
Enkephalin-mimetic cosmetic peptide that reduces expression wrinkles by modulating acetylcholine release at the neuromuscular junction, offering a Botox-like topical alternative.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Dosing
How much do I take?
Topical: Applied onto the skin as a cream, gel, or lotion — it works mainly where you put it.
Bioavailability Local — acts mainly at the skin; little reaches the bloodstream.
2 documented dose levels — separate regimens, not a titration schedule
2% Leuphasyl in formulation
Frequency
Once or twice daily
Duration
4-8 weeks
Lowest concentration shown to give significant wrinkle reduction in cosmetic testing; 2% was the threshold at which measurable improvement appeared over ~2 months of daily use [6].
5% Leuphasyl in formulation
Frequency
Once or twice daily
Duration
At least 4 weeks
Manufacturer in-vivo concentration; 5% Leuphasyl reduced wrinkles ~11% after 28 days, and ~25% (up to 47%) when paired with 5% Argireline [6].
Timing
Best time to take
Apply Leuphasyl to clean, dry skin. For best results, use consistently at the same time(s) each day. Evening application is often preferred to allow overnight absorption, unless otherwise directed.
With food?
As a topical product, Leuphasyl is not affected by food intake. Apply to clean skin and allow adequate absorption time before covering the area.
If stacking
Leuphasyl should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting your dose
Increase if
- You've tolerated the current dose for the recommended period without significant side effects
- Therapeutic goals haven't been met at the current dose level
- Your healthcare provider recommends dose escalation based on your response
- Lab work or clinical assessments support a higher dose
Decrease if
- Side effects are bothersome or impacting daily life despite management strategies
- You experience any signs of an adverse reaction
- Lab results indicate the need for dose reduction
- Your healthcare provider recommends a lower dose based on your response
Signs of right dose
- Therapeutic goals being met with minimal side effects
- Stable and consistent response to treatment
- Lab values or clinical markers trending in the right direction
- Good tolerance with manageable or absent side effects
Administration
How do I use it?
Reconstitution
What you need
Injection
Route
Leuphasyl is administered Topical application (serums, creams, ampoules)—no injection required
Best sites
Storage
Before reconstitution
Store Leuphasyl in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Leuphasyl should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation — discard the vial
Sample daily schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Topical application (serums, creams, ampoules)—rotate sites if applicable
Maintain a consistent schedule for optimal results with Leuphasyl. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Safety
Is it safe?
Side effects
Commonly reported: Mild discomfort at treatment site, Mild skin tingling, Mild redness at application site
Less common: Temporary skin dryness
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Leuphasyl
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Leuphasyl should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Published research
What the studies show
Zdrada-Nowak J, et al. · 2025
This comprehensive review demonstrates that neuromuscular-targeting peptides like Leuphasyl achieve meaningful wrinkle reduction through acetylcholine modulation. The review documents Leuphasyl-Argireline synergy with combined efficacy approximately 2.3-fold greater than either peptide used alone, reaching 25% wrinkle depth reduction with complementary presynaptic and postsynaptic mechanisms.
Bang J, et al. · 2024
This study of neuromuscular junction-targeting peptides contextualizes Leuphasyl's enkephalin-receptor mechanism within the broader landscape of neurocosmetic peptides. The research demonstrates that targeting acetylcholine pathways at the presynaptic level (as Leuphasyl does) produces measurable wrinkle improvement comparable to other neuromuscular approaches.
Skibska A, et al. · 2021
This review of biomimetic peptides in cosmetics discusses Leuphasyl's mechanism and efficacy data, positioning it within the neurocosmetic peptide category. The review confirms that enkephalin-mimetic approaches produce reversible, topical neuromuscular modulation suitable for expression wrinkle prevention and reduction.
Mark Qian K, et al. · 2025
This study demonstrates synergistic effects of multi-peptide formulations in anti-aging applications. The research supports combining Leuphasyl with complementary peptides (like Argireline) for enhanced anti-aging benefits, showing cumulative effects that exceed single-peptide formulations.
Liu Z, et al. · 2024
This evaluation of cosmetic peptide methodologies provides context for assessing Leuphasyl's efficacy through standardized measurement techniques including silicone imprints and image analysis, confirming that 11% wrinkle reduction at 5% concentration represents documented, measurable cosmetic efficacy.
INCIDecoder · 2024
Cosmetic testing: 2% was the lowest concentration giving significant wrinkle reduction over ~2 months; manufacturer in-vivo data show 5% reduced wrinkles ~11% at 28 days and ~25% (up to 47%) combined with 5% Argireline.
Head to head
Leuphasyl compared
Want the full picture?
The complete Leuphasyl research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.